Clinical Trials Logo

Hypoxia clinical trials

View clinical trials related to Hypoxia.

Filter by:

NCT ID: NCT01795534 Completed - Hypoxia Clinical Trials

Beetroot Juice as a Potential Ergogenic Aid During Exercise in Hypoxia

Start date: February 2013
Phase: N/A
Study type: Interventional

The study will aim to describe and evaluate the effect of beetroot juice supplementation upon whole body running exercise at altitude. It is hypothesised that beetroot supplementation will decrease time to complete a 10 km time trial.

NCT ID: NCT01793129 Completed - Infant, Newborn Clinical Trials

Preemie Hypothermia for Neonatal Encephalopathy

Start date: May 2015
Phase: N/A
Study type: Interventional

This study is a randomized, controlled trial to assess safety and effectiveness of whole body hypothermia for 72 hours in preterm infants 33-35 weeks gestational age (GA) who present at <6 hours postnatal age with moderate to severe neonatal encephalopathy (NE). The study will enroll infants with signs of NE at 18 NICHD Neonatal Research Network sites, and randomly assign them to either receive hypothermia or participate in a non-cooled control group.

NCT ID: NCT01765218 Terminated - Clinical trials for Hypoxic Ischemic Encephalopathy

Topiramate in Neonates Receiving Whole Body Cooling for Hypoxic Ischemic Encephalopathy

Start date: February 2013
Phase: Phase 1/Phase 2
Study type: Interventional

The goal is to see whether topiramate (an anti-epileptic agent) improves the outcome of babies with neonatal hypoxic encephalopathy who are receiving whole body cooling.

NCT ID: NCT01732146 Completed - Clinical trials for Hypoxic Ischemic Encephalopathy

Efficacy of Erythropoietin to Improve Survival and Neurological Outcome in Hypoxic Ischemic Encephalopathy

Neurepo
Start date: March 28, 2013
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine the efficacy of high dose Erythropoietin to improve survival and neurologic outcome in asphyxiated term newborn undergoing cooling.

NCT ID: NCT01725464 Completed - Hypoxia Clinical Trials

The Effect of Nasal Cannula During the First 2 Hours Postoperative in Patient Undergoing Thoracotomy

Start date: November 2012
Phase: Phase 4
Study type: Interventional

During early postoperative after lung resection surgery, patients without oxygen supplementation may experience hypoxemia. Oxygen supplementation can be given via oxygen mask or cannular. In this study the investigators want to the sudy the effect of oxygen supplementation via oxygen cannular during the first 120 minutes after surgery

NCT ID: NCT01700088 Completed - Hypoxia Clinical Trials

The Effect of Nasal Cannulae During the First 2 Hours Postoperative in Patient Undergoing Thoracotomy

Start date: November 2012
Phase: N/A
Study type: Observational

At our institute,during the first 2 hour postoperative, we used to give supplement oxygen via face mask in patient having lung resection surgery. After then if the patient is fine, we'll replace the face mask with nasal cannular untie the next morning. We hypothesized that oxygen mask can be replace by nasal cannular without any hypoxia.

NCT ID: NCT01689090 Completed - Clinical trials for Diabetes Mellitus Type 1

Diameter Changes of Retinal Vessels During Hypoxia

Start date: November 2012
Phase: N/A
Study type: Interventional

The primary objective is to study if an inhibition of nitric oxide and/or prostaglandins affect the diameter changes of retinal vessels observed during hypoxia. Diameter changes are studied using the Dynamic Vessel Analyzer.

NCT ID: NCT01681238 Active, not recruiting - Hypoxia Clinical Trials

Goal-directed Therapy in High-risk Surgery

Start date: September 2012
Phase: N/A
Study type: Interventional

There is growing evidence that the risk of postoperative complications can be decreased by optimizing the amount and type of infusion fluids given during surgery, steered by goal-directed therapy based on flow-related hemodynamic parameters, particularly in high-risk patients. This study is undertaken subsequently to test the hypothesis that the intraoperative goal-directed strategy based on FloTrac/Vigileo, a minimally invasive monitor, can partially prevented postoperative complications and shorten hospital stay in the elderly high-risk patients undergoing total hip replacement with continuous spinal anaesthesia .

NCT ID: NCT01662544 Active, not recruiting - Hypoxia Clinical Trials

Heated High Flow Oxygen Use in Infants With Bronchiolitis and Hypoxia

HHFNC
Start date: August 2012
Phase: N/A
Study type: Interventional

Bronchiolitis is a common cold weather seasonal respiratory illness affecting infants and children. Multiple supportive therapies have been tried in infants with bronchiolitis including albuterol, racemic epinephrine, hypertonic saline nebulization, but to date supportive therapy with oxygen is the only proven therapy to decrease respiratory distress in infants with bronchiolitis, with hypertonic saline showing a borderline statistically significant improvement. This prospective, randomized study will compare CSS and PEWS scores on infants who receive oxygen by standard flow nasal cannula and to those who receive oxygen via Humidified High-Flow Nasal Cannula (HHFNC). The results will help determine if infants with viral bronchiolitis who receive humidified high flow nasal cannula oxygen therapy have improved Clinical Severity Score (CSS) and Pediatric Early Warning System (PEWS) scores and ultimately decreased lengths of admissions when compared to patients treated with nasal cannula oxygen therapy with/without bronchodilator therapy. Hypothesis Heated Humidified High-flow Nasal Cannula Delivery of Oxygen decreases respiratory distress as measured by pediatric CSS and PEWS when compared with routine nasal cannula oxygen delivery in infants with bronchiolitis.

NCT ID: NCT01650974 Completed - Hypoxia Clinical Trials

High Flow Nasal OXygen Therapy in High Risk Patients of Hypoxia Undergoing Diagnostic BRONCHOscopy

HFNOT
Start date: July 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the efficacy and safety of nasal high flow oxygen therapy during diagnostic bronchoscopy.